Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The cholesterol pathway: impact on immunity and cancer
Ryan J. King, Pankaj K. Singh, Kamiya Mehla
Trends in Immunology (2021) Vol. 43, Iss. 1, pp. 78-92
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
Xuemeng Xu, Peng Qiu, Xianjie Jiang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1357-1370
Open Access | Times Cited: 95
Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non–small cell lung cancer
Wenjun Mao, Yun Cai, Danrong Chen, et al.
JCI Insight (2022) Vol. 7, Iss. 18
Open Access | Times Cited: 91
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
Xuhui Bao, Yongjun Liang, Hanman Chang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 50
Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis‐Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment
Yuan Zhi, Qian Wang, Moxin Zi, et al.
Advanced Science (2024) Vol. 11, Iss. 12
Open Access | Times Cited: 21
A Cholesterol Metabolic Regulated Hydrogen‐Bonded Organic Framework (HOF)‐Based Biotuner for Antibody Non‐Dependent Immunotherapy Tailored for Glioblastoma
Na Yin, Yinghui Wang, Yang Liu, et al.
Advanced Materials (2023) Vol. 35, Iss. 44
Closed Access | Times Cited: 41
Review of Eukaryote Cellular Membrane Lipid Composition, with Special Attention to the Fatty Acids
Omeralfaroug Ali, András Szabó
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15693-15693
Open Access | Times Cited: 37
Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy
Xuehan Qiao, Zhangmin Hu, Fen Xiong, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 35
Multi‐Enzyme Co‐Expressed Nanomedicine for Anti‐Metastasis Tumor Therapy by Up‐Regulating Cellular Oxidative Stress and Depleting Cholesterol
Yang Liu, Rui Niu, Ruiping Deng, et al.
Advanced Materials (2023) Vol. 36, Iss. 2
Open Access | Times Cited: 34
Cholesterol-binding motifs in STING that control endoplasmic reticulum retention mediate anti-tumoral activity of cholesterol-lowering compounds
Bao‐cun Zhang, Marlene Fyrstenberg Laursen, Lili Hu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Cancer immunometabolism: advent, challenges, and perspective
Qin Dang, Borui Li, Bing Jin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities
Wen G. Jiang, Weilin Jin, Aman Xu
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2044-2071
Open Access | Times Cited: 8
Targeting ACAT1 in cancer: from threat to treatment
Tie Sun, Xuan Xiao
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Lipid Metabolism: An Emerging Player in Sjögren’s Syndrome
Keni Chang, Peiming Luo, Zizhen Guo, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access | Times Cited: 1
Viral Hepatitis, Cholesterol Metabolism, and Cholesterol-Lowering Natural Compounds
Je-Wen Liou, Hemalatha Mani, Jui-Hung Yen
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3897-3897
Open Access | Times Cited: 29
Cholesterol: An important actor on the cancer immune scene
Hossein Halimi, Shirin Farjadian
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Trogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape
You Zhai, Yicong Du, LI Guan-zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 19
Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells
Pingshan Zhong, Kohei Nakata, Koki Oyama, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Inhibition of DUSP18 impairs cholesterol biosynthesis and promotes anti-tumor immunity in colorectal cancer
Xiaojun Zhou, Genxin Wang, Chenhui Tian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Hypercholesterolemia Is Associated With Dysregulation of Lipid Metabolism and Poor Prognosis in Primary Biliary Cholangitis
Linhua Zheng, Siyuan Tian, Chunmei Yang, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 6, pp. 1265-1274.e19
Open Access | Times Cited: 5
Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response
Man‐Yu Xiao, Wenjing Pei, Si Li, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107539-107539
Closed Access | Times Cited: 5
Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy
Xin Su, Jian Li, Xiao–Ming Xu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Health interest of cholesterol and phytosterols and their contribution to One Health approach: Review
Souleymane Zio, Bakary Tarnagda, François Tapsoba, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e40132-e40132
Closed Access | Times Cited: 5
Glycolysis-cholesterol metabolic axis in immuno-oncology microenvironment: emerging role in immune cells and immunosuppressive signaling
Jing Jin, Qijie Zhao, Zhigong Wei, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy
Hongyan Zhang, Yujie Li, Jingyi Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4717-4737
Open Access | Times Cited: 4
The Influence of Cholesterol on Membrane Targeted Bioactive Peptides: Modulating Peptide Activity Through Changes in Bilayer Biophysical Properties
Juan M. Giraldo-Lorza, Chad Leidy, Marcela Manrique-Moreno
Membranes (2024) Vol. 14, Iss. 10, pp. 220-220
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top